118 related articles for article (PubMed ID: 33278770)
1. Development and validation of a pancreatic cancer risk model for the general population using electronic health records: An observational study.
Appelbaum L; Cambronero JP; Stevens JP; Horng S; Pollick K; Silva G; Haneuse S; Piatkowski G; Benhaga N; Duey S; Stevenson MA; Mamon H; Kaplan ID; Rinard MC
Eur J Cancer; 2021 Jan; 143():19-30. PubMed ID: 33278770
[TBL] [Abstract][Full Text] [Related]
2. A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data.
Jia K; Kundrot S; Palchuk MB; Warnick J; Haapala K; Kaplan ID; Rinard M; Appelbaum L
EBioMedicine; 2023 Dec; 98():104888. PubMed ID: 38007948
[TBL] [Abstract][Full Text] [Related]
3. Phenotype risk scores (PheRS) for pancreatic cancer using time-stamped electronic health record data: Discovery and validation in two large biobanks.
Salvatore M; Beesley LJ; Fritsche LG; Hanauer D; Shi X; Mondul AM; Pearce CL; Mukherjee B
J Biomed Inform; 2021 Jan; 113():103652. PubMed ID: 33279681
[TBL] [Abstract][Full Text] [Related]
4. A case-control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer.
Keane MG; Horsfall L; Rait G; Pereira SP
BMJ Open; 2014 Nov; 4(11):e005720. PubMed ID: 25410605
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of Case-Finding Algorithms to Identify Pancreatic Cancer in the Veterans Health Administration.
Mezzacappa C; Larki NR; Skanderson M; Park LS; Brandt C; Hauser RG; Justice A; Yang YX; Wang L
Dig Dis Sci; 2024 Apr; 69(4):1507-1513. PubMed ID: 38453743
[TBL] [Abstract][Full Text] [Related]
6. Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data.
Baecker A; Kim S; Risch HA; Nuckols TK; Wu BU; Hendifar AE; Pandol SJ; Pisegna JR; Jeon CY
PLoS One; 2019; 14(6):e0218580. PubMed ID: 31237889
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier.
Bhasin MK; Ndebele K; Bucur O; Yee EU; Otu HH; Plati J; Bullock A; Gu X; Castan E; Zhang P; Najarian R; Muraru MS; Miksad R; Khosravi-Far R; Libermann TA
Oncotarget; 2016 Apr; 7(17):23263-81. PubMed ID: 26993610
[TBL] [Abstract][Full Text] [Related]
8. The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort.
Choi JH; Lee SH; Huh G; Chun JW; You MS; Paik WH; Ryu JK; Kim YT
Cancer Med; 2019 Dec; 8(17):7419-7430. PubMed ID: 31637875
[TBL] [Abstract][Full Text] [Related]
9. Dynamic ElecTronic hEalth reCord deTection (DETECT) of individuals at risk of a first episode of psychosis: a case-control development and validation study.
Raket LL; Jaskolowski J; Kinon BJ; Brasen JC; Jönsson L; Wehnert A; Fusar-Poli P
Lancet Digit Health; 2020 May; 2(5):e229-e239. PubMed ID: 33328055
[TBL] [Abstract][Full Text] [Related]
10. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
Yu S; Li Y; Liao Z; Wang Z; Wang Z; Li Y; Qian L; Zhao J; Zong H; Kang B; Zou WB; Chen K; He X; Meng Z; Chen Z; Huang S; Wang P
Gut; 2020 Mar; 69(3):540-550. PubMed ID: 31562239
[TBL] [Abstract][Full Text] [Related]
11. Prediction of myopia development among Chinese school-aged children using refraction data from electronic medical records: A retrospective, multicentre machine learning study.
Lin H; Long E; Ding X; Diao H; Chen Z; Liu R; Huang J; Cai J; Xu S; Zhang X; Wang D; Chen K; Yu T; Wu D; Zhao X; Liu Z; Wu X; Jiang Y; Yang X; Cui D; Liu W; Zheng Y; Luo L; Wang H; Chan CC; Morgan IG; He M; Liu Y
PLoS Med; 2018 Nov; 15(11):e1002674. PubMed ID: 30399150
[TBL] [Abstract][Full Text] [Related]
12. Derivation and External Validation of Machine Learning-Based Model for Detection of Pancreatic Cancer.
Chen W; Zhou Y; Xie F; Butler RK; Jeon CY; Luong TQ; Zhou B; Lin YC; Lustigova E; Pisegna JR; Kim S; Wu BU
Am J Gastroenterol; 2023 Jan; 118(1):157-167. PubMed ID: 36227806
[TBL] [Abstract][Full Text] [Related]
13. The Main Bottleneck for Non-Metastatic Pancreatic Adenocarcinoma in Past Decades: A Population-Based Analysis.
Li Y; Liu W; Zhao L; Xu Y; Yan T; Yang Q; Pei Q; Güngör C
Med Sci Monit; 2020 May; 26():e921515. PubMed ID: 32358953
[TBL] [Abstract][Full Text] [Related]
14. Surveillance for pancreatic cancer in high-risk individuals.
Konings ICAW; Canto MI; Almario JA; Harinck F; Saxena P; Lucas AL; Kastrinos F; Whitcomb DC; Brand RE; Lachter J; Malleo G; Paiella S; Syngal S; Saltzman JR; Stoffel EM; van Hooft JE; Hruban RH; Poley JW; Fockens P; Goggins MG; Bruno MJ;
BJS Open; 2019 Oct; 3(5):656-665. PubMed ID: 31592073
[TBL] [Abstract][Full Text] [Related]
15. Predicting hospitalizations from electronic health record data.
Morawski K; Dvorkis Y; Monsen CB
Am J Manag Care; 2020 Jan; 26(1):e7-e13. PubMed ID: 31951361
[TBL] [Abstract][Full Text] [Related]
16. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients.
Dugnani E; Gandolfi A; Balzano G; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
Pancreatology; 2016; 16(5):844-52. PubMed ID: 27546476
[TBL] [Abstract][Full Text] [Related]
17. Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients.
Blyuss O; Zaikin A; Cherepanova V; Munblit D; Kiseleva EM; Prytomanova OM; Duffy SW; Crnogorac-Jurcevic T
Br J Cancer; 2020 Mar; 122(5):692-696. PubMed ID: 31857725
[TBL] [Abstract][Full Text] [Related]
18. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
[TBL] [Abstract][Full Text] [Related]
19. Can the Use of Bayesian Analysis Methods Correct for Incompleteness in Electronic Health Records Diagnosis Data? Development of a Novel Method Using Simulated and Real-Life Clinical Data.
Ford E; Rooney P; Hurley P; Oliver S; Bremner S; Cassell J
Front Public Health; 2020; 8():54. PubMed ID: 32211363
[No Abstract] [Full Text] [Related]
20. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
